ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Shareholders’ equity 2020–2025
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) shareholders’ equity at each fiscal year-end, per SEC filings.
$189.5MFY2025 · since FY2020: $270.6M → $189.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $189.5M | +20.3% |
| FY2024 | $157.5M | +77.7% |
| FY2023 | $88.7M | -57.7% |
| FY2022 | $209.6M | -29.6% |
| FY2021 | $297.7M | +10.0% |
| FY2020 | $270.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice